These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2921774)

  • 1. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.
    Dvorak HF; Gresser I
    J Natl Cancer Inst; 1989 Apr; 81(7):497-502. PubMed ID: 2921774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice.
    Gresser I; Carnaud C; Maury C; Sala A; Eid P; Woodrow D; Maunoury MT; Belardelli F
    J Exp Med; 1991 May; 173(5):1193-203. PubMed ID: 2022926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor.
    Gresser I; Belardelli F; Tavernier J; Fiers W; Podo F; Federico M; Carpinelli G; Duvillard P; Prade M; Maury C
    Int J Cancer; 1986 Nov; 38(5):771-8. PubMed ID: 3464571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
    Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
    Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases.
    Kaido T; Gresser I; Maury C; Maunoury MT; Vignaux F; Belardelli F
    Int J Cancer; 1993 May; 54(3):475-81. PubMed ID: 8509222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
    Proietti E; Carpinelli G; Di Vito M; Belardelli F; Gresser I; Podo F
    Cancer Res; 1986 Jun; 46(6):2849-57. PubMed ID: 2421886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of murine interferon-alpha/beta-sensitive and -resistant friend leukemia cells with tumor necrosis factor in combination with murine interferon-alpha/beta or -gamma.
    Van der Heyden J; Fransen L; Fiers W
    J Interferon Res; 1986 Dec; 6(6):633-8. PubMed ID: 3106522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action.
    Sala A; Gresser I; Chassoux D; Maury C; Santodonato L; Eid P; Maunoury MT; Barca S; Cianfriglia M; Belardelli F
    Cancer Res; 1992 May; 52(10):2880-9. PubMed ID: 1581903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or beta.
    Belardelli F; Proietti E; Ciolli V; Sestili P; Carpinelli G; Di Vito M; Ferretti A; Woodrow D; Boraschi D; Podo F
    Int J Cancer; 1989 Jul; 44(1):116-23. PubMed ID: 2787294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mouse interferon alpha/beta on the expression of H-2 (class I) antigens and on the levels of 2'-5' oligoadenylate synthetase activity in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
    Locardi C; Belardelli F; Federico M; Romeo G; Affabris E; Gresser I
    J Biol Regul Homeost Agents; 1987; 1(4):189-94. PubMed ID: 3332546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
    Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. III. Inhibition of growth and necrosis of tumors implanted subcutaneously.
    Belardelli F; Gresser I; Maury C; Duvillard P; Prade M; Maunoury MT
    Int J Cancer; 1983 May; 31(5):649-53. PubMed ID: 6189790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.
    Santodonato L; Ferrantini M; Gabriele L; Proietti E; Venditti M; Musiani P; Modesti A; Modica A; Lupton SD; Belardelli F
    Hum Gene Ther; 1996 Jan; 7(1):1-10. PubMed ID: 8825863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice.
    Gresser I; Maury C; Vignaux F; Haller O; Belardelli F; Tovey MG
    J Exp Med; 1988 Oct; 168(4):1271-91. PubMed ID: 3171480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice.
    Gresser I; Kaido T; Maury C; Woodrow D; Moss J; Belardelli F
    Int J Cancer; 1994 May; 57(4):604-11. PubMed ID: 8181864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of interferon alpha in the resistance of allogeneic C57B1/6 mice to the multiplication of Friend erythroleukemia cells in the liver.
    Gresser I; Maury C; Bandu MT; Belardelli F
    Int J Cancer; 1990 Feb; 45(2):364-71. PubMed ID: 2406205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases.
    Gresser I; Maury C; Belardelli F
    Int J Cancer; 1987 Jun; 39(6):789-92. PubMed ID: 2438237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural resistance in mice against Friend cells injected intravenously. III. Comparison between in vivo and in vitro passaged interferon-sensitive (745) and interferon-resistant (3Cl8) cell clones.
    Neri M; Zei T; Bonmassar E; Rossi GB; Fiorucci G; Iorio AN
    Br J Cancer; 1989 Jun; 59(6):848-53. PubMed ID: 2736222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
    Gresser I; Maury C; Woodrow D; Moss J; Grütter MG; Vignaux F; Belardelli F; Maunoury MT
    Int J Cancer; 1988 Jan; 41(1):135-42. PubMed ID: 3422071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.
    Gabriele L; Kaido T; Woodrow D; Moss J; Ferrantini M; Proletti E; Santodonato L; Rozera C; Maury C; Belardelli F
    Am J Pathol; 1995 Aug; 147(2):445-60. PubMed ID: 7639337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.